Health activists and patients with spinal muscular atrophy (SMA) have refuted the ... but is universally marked by progressive muscle weakness and loss of function. Over 8,500 people, ranging ...
The Amsterdam-based biotech firm said that its melt curve analysis-based test is used as a first-tier genetic screening tool to aid the diagnosis of SMA.
In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...
More research is needed to confirm gray matter, the darker tissue found in the brain and spinal cord, “as a potential disease ...
for patients of spinal muscular atrophy (SMA) costs Rs 72 lakhs a year in India. A case in this regard has been going on in the Kerala High Court for a while now. On 22nd the Central government ...
The following is a summary of “Spinal cord gray matter atrophy is associated with disability in spinal muscular atrophy,” ...